Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI) [Phase 4]
Phase 4 trial of Creon (pancrelipase) in pancreatic cancer patients with exocrine pancreatic insufficiency has been terminated; results post…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase II trial evaluating gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer has completed.
-
FDA approval · 2023-05-31FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP, resulting in changes to the product…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy [Phase 1]
Phase 1 trial of a neoantigen peptide vaccine strategy in pancreatic cancer patients following surgical resection and adjuvant chemotherapy …
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Terlipressin Infusion During Whipple Procedure: Effect on Blood Loss and Transfusion Needs [Phase 2]
Phase 2 trial update evaluating terlipressin infusion during Whipple procedure and its effect on blood loss and transfusion needs.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial [Phase 2]
Phase 2 trial update evaluating Niraparib in metastatic pancreatic cancer after prior chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial investigating BATS with low-dose IL-1 and GM-CSF in advanced pancreatic cancer (Phase 1/2) has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine [Phase 2]
Phase 2 trial comparing cardiovascular side effects of Teysuno versus capecitabine in gastrointestinal cancers completed.
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy [Phase 3]
Phase 3 trial evaluating early palliative care in patients with metastatic upper gastrointestinal cancers treated with first-line chemothera…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 trial assessing paclitaxel albumin-stabilized nanoparticles with or without AZD1775 in previously untreated metastatic or unresect…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Efficacy and Safety of PARPi to Treat Pancreatic Cancer [Phase 2]
Phase 2 trial assessing PARP inhibitor efficacy and safety in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]
Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal ca…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial of ascorbic acid combined with nab-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer [NA]
A completed clinical trial investigating preoperative biliary drainage in patients with resectable pancreatic or periampullary cancer; resul…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating anlotinib plus a PD-1 inhibitor as second-line therapy for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating irinotecan, oxaliplatin, and S1 in patients with advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX [Phase 3]
A Phase 3 trial comparing EndoTAG-1+GEM versus GEM in locally advanced or metastatic pancreatic adenocarcinoma after FOLFIRINOX failure has …
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for albumin-bound docetaxel in pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers [Phase 2]
Phase 2 trial of perioperative MVT-5873, a CA 19-9 epitope–targeting monoclonal antibody, in operable CA 19-9–producing pancreatic cancers, …
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating circulating tumor cells as tools for monitoring therapy response in patients with metastatic pancreatic ca…
-
FDA approval · 2023-03-07FDA Approved: GEMCITABINE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic gemcitabine under an Original Application (ANDA). This marks the approval of a generic…
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of gemcitabine plus nab-paclitaxel with or without FG-3019 in locally advanced, unresectable pancreatic cancer has completed…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 study evaluating cyclophosphamide, pembrolizumab, GVAX Pancreas Vaccine, and SBRT in locally advanced pancreatic cancer has complete…